Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Other Gross PP&E Adjustments (2017 - 2025)

Organogenesis Holdings has reported Other Gross PP&E Adjustments over the past 9 years, most recently at $79.2 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $79.2 million for Q4 2025, up 0.83% from a year ago — trailing twelve months through Dec 2025 was $79.2 million (up 0.83% YoY), and the annual figure for FY2025 was $79.2 million, up 0.83%.
  • Other Gross PP&E Adjustments for Q4 2025 was $79.2 million at Organogenesis Holdings, up from $73.8 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for ORGO hit a ceiling of $116.8 million in Q2 2023 and a floor of -$23.0 million in Q2 2024.
  • Median Other Gross PP&E Adjustments over the past 5 years was $72.4 million (2021), compared with a mean of $64.7 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 119.66% in 2024 and later skyrocketed 415.95% in 2025.
  • Organogenesis Holdings' Other Gross PP&E Adjustments stood at $39.6 million in 2021, then skyrocketed by 38.97% to $55.1 million in 2022, then crashed by 46.48% to $29.5 million in 2023, then surged by 166.54% to $78.5 million in 2024, then rose by 0.83% to $79.2 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $79.2 million (Q4 2025), $73.8 million (Q3 2025), and $72.6 million (Q2 2025) per Business Quant data.